Market Synopsis of Global Sciatica Market
Market Scenario
Sciatica is characterized by pain
going down the leg from the lower back due to irritation of the lumbar or
sacral nerves. Sciatica is triggered by activities like heavy lifting and jerky
movements. However the condition can also develop gradually. Typically,
sciatica symptoms occur on one side of the body although in some cases the pain
can be on both sides. The other symptoms of sciatica are weakness or numbness
in the affected leg, burning or tingling down the affected leg, and constant
pain on one side of the rear. The causes of sciatica are spondylolisthesis,
muscle spasm in the back or buttock, spinal stenosis, piriformis syndrome,
pelvic tumours, pregnancy and others. However, spinal disc herniation is the
primary cause of sciatica in about 90% of the cases. Other uncommon causes are
lumbar degenerative disc disease, osteophytes and arthritis of the spine.
Get Sample
Copy @ https://www.marketresearchfuture.com/sample_request/4767
Sciatica generally resolves on its
own in about 90% of the cases. However it can result in severe pain which may
need surgical intervention. Surgery may be required if complications occur such
as bowel or bladder problems. Sciatica affects 40% of people at some point in
their life time. Sciatica is most common during people's 40s and 50s, and men
are more frequently affected than women.
The market drivers for global
sciatica market are rise in demand due to growing population, increasing
screening, rising cases of geriatrics, rising safety and success of drug
treatment, the extricating nature of the pain and others. The market restraints
are the complications of surgery such as risk of bleeding, infections, pain,
high cost of sciatica treatment, and others.
The global sciatica market is
expected to reach USD 18.9 billion by 2023, and the market is projected to grow
at a CAGR of ~ 8.0 % during the forecast period 2017-2023.
Research Methodology
Sources: Mayo Clinic, Healthline Media, MRFR Analysis
Intended Audience
- Global Sciatica manufacturers & suppliers
- Research and development (R&D) companies
- Hospitals and clinics
- Academic institutes and universities
Figure 1 Global Sciatica Market by Drug Treatment, 2016 (%)
Segments
The global sciatica market has been
segmented on the basis of types, drug treatment, devices and end user.
Based on the types, the market has
been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root
sciatica and others.
Based on the drugs, the market has
been segmented as anesthetics, pain killers, muscle relaxants, antidepressants,
steroids and others.
Based on the non-drug treatment, the
market has been segmented as physiotherapy, acupuncture, stimulation
devices, surgery and others.
Based on the end user, the market
has been segmented as hospitals and clinics, research and academics and others.
Regional Analysis
The Americas accounts for a
significant market share owing to high expenditure on the healthcare especially
of the U.S. and Canada. Additionally, greater number of orthopedic procedures
due to greater healthcare penetration in the U.S. and Canada drives the
sciatica market. The high concentration of the major hospitals in the developed
countries of this region coupled with good reimbursement rates is adding fuel
to the market growth. Moreover, the large share of surgical procedures
especially the sciatica treatment in the returns of hospitals favors the
market. A large number of medical devices companies in the U.S. is also a cause
for the faster development of sciatica market in the US.
Europe is the second largest market
in the world due to the growing medical devices industry and healthcare
penetration. The European market growth is led by countries such as Germany and
France. Germany is expected to be the fastest growing market over the
assessment period due to its large medical devices industry.
Asia Pacific region is expected to
grow rapidly where China and India are likely to lead the market due to faster
growing healthcare sector and larger unmet needs over the forecast period. The
South East Asian countries such as China, India, and Malaysia are projected to
contribute highly to the market growth. The growing penetration of healthcare
industry in the Asia Pacific region is expected to drive the future sciatica
market in the region.
Gulf nations such as Saudi Arabia
and the UAE are estimated to drive the Middle East & African market. Other
Middle Eastern nations to watch out for are Kuwait, Jordan, Egypt and Iran. The
African region is expected to witness a poor growth owing to poor economic and
political conditions, and poor healthcare development. Other regions are
expected to be laggards due to poor social development and tribal identities
such as sub Saharan Africa.
Key Players in the Global Sciatica
Market
Some of the key players profiled in
the report are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva
Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems
Ltd., Omron Healthcare, Inc., Sanofi and others.
Browse More Details @ https://www.marketresearchfuture.com/reports/sciatica-market-4767
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment